Similarly, Pan et al. [17] suggest that MT2A exerts tumor suppressive activity and observe that decreased MT2A expression in cell lines and primary tumors correlates with advanced clinical stage and poor prognosis in gastric cancer. This evidence concerns the gene MT2A and gastric cancer.